Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,018 | -30,986 | -20,789 | -1,898 | -5,917 |
| Depreciation Amortization | 2,658 | 1,917 | 2,296 | 1,134 | 1,233 |
| Accounts receivable | -321 | -463 | 44 | 2,274 | -1,505 |
| Other Working Capital | -702 | -2,130 | -1,889 | 163 | -4,438 |
| Other Operating Activity | 3,675 | 4,241 | 3,092 | 393 | 3,044 |
| Operating Cash Flow | $-36,708 | $-27,421 | $-17,246 | $2,066 | $-7,583 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27,069 | -19,633 | 14,865 | 3,335 | -11,496 |
| PPE Investments | -2,409 | -1,442 | -2,220 | -1,265 | -1,325 |
| Other Investing Activity | -3 | -401 | -130 | 0 | 0 |
| Investing Cash Flow | $24,657 | $-21,476 | $12,515 | $2,070 | $-12,821 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -12 | -105 |
| Common Stock Issued | 5,441 | 57,669 | 1,418 | 1,007 | 1,926 |
| Other Financing Activity | 0 | -4,382 | 0 | 0 | 0 |
| Financing Cash Flow | $5,441 | $53,287 | $1,418 | $995 | $1,821 |
| Beginning Cash Position | 11,837 | 7,447 | 10,760 | 5,629 | 24,213 |
| End Cash Position | 5,227 | 11,837 | 7,447 | 10,760 | 5,629 |
| Net Cash Flow | $-6,610 | $4,390 | $-3,313 | $5,131 | $-18,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,708 | -27,421 | -17,246 | 2,066 | -7,583 |
| Capital Expenditure | -2,409 | -1,442 | -2,220 | -1,265 | -1,325 |
| Free Cash Flow | -39,117 | -28,863 | -19,466 | 801 | -8,908 |